Vancomycin News
Most Popular Vancomycin Story
Optimer shares buoyed by promising Ph3 C. diff data
Shares of Optimer Pharmaceuticals zoomed up 20 percent after the developer announced another set of promising data from a large, late-stage study of its experimental antibiotic, fidaxomicin. And the Read more...
Latest Headlines
- February 3, 2011
- February 5, 2010
- November 20, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
